Latest news from EU institutions and bodies

EBA, EIOPA and ESMA propose amendments to bilateral margin requirements 03 August 2026 Joint Committee Trading The European Supervisory Authorities (EBA, EIOPA and ESMA – the ESAs) today published a final report on draft Regulatory...

EBA, EIOPA and ESMA call for enhanced governance and consistent supervision to mitigate ICT risks from frontier AI models in the EU financial sector 31 July 2026 Digital Finance and Innovation Joint Committee The European Supervisory...

ESMA publishes latest edition of its newsletter 31 July 2026 ESMA newsletter The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, has published today the latest edition of its Spotlight on...

ESMA authorises EuroCTP as the Consolidated Tape Provider for shares and exchange-traded funds 27 July 2026 Market data Press Releases Trading The European Securities and Markets Authority (ESMA), the EU’s financial...

ESMA calls on firms to finalise preparations ahead of T+1 settlement deadlines 20 July 2026 Post Trading The European Securities and Markets Authority (ESMA), the EU regulator and supervisor, has published a statement highlighting key deadlines and...

ESMA publishes report on cross-border investment services supervision 20 July 2026 Supervisory convergence The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, today published its follow-up...

A new supply chain for Visudyne (verteporfin) has been put in place in the European Union (EU), marking an important step towards resolving a long-standing shortage of the…, This situation shows the complexity of shortages and how coordination between the European Commission, EU Member...

The EU4Health project CHIP-AML22 is working to improve treatment outcomes for children with AML by advancing targeted treatments that reduce the level of toxicity and guarantee more equal outcomes across Europe.